(PGNX) |
| 0 (0%) 06-03 15:49 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 11.15 |
| Resistance 1: | 11.05 |
| Pivot price: | 10.99 |
| Support 1: | 10.88 |
| Support 2: | 9.05 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 18 Nov 2022
David A Scheinberg Net Worth (2026) - GuruFocus
Wed, 17 Jul 2019
Court Upholds The Validity And Determined Actavis' Infringement Of Patent Protecting RELISTOR® Tablets - PR Newswire
Wed, 20 Jul 2016
Valeant wins FDA oral Relistor approval and $1B sales potential - Fierce Biotech
Tue, 22 Jul 2014
Kevin Kotler, Broadfin Capital Increase Holding Of Progenics Pharmaceuticals, Inc. (PGNX) - Insider Monkey
Tue, 22 Jan 2013
Progenics Acquires Molecular Insight Pharmaceuticals to Expand Oncology-Focused Pipeline - GlobeNewswire
Wed, 03 Jun 2026
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
